Total Payments
$5,544
2024 Payments
$1,242
Companies
42
Transactions
166
Medicare Patients
2,714
Medicare Billing
$262,205
Payment Breakdown by Category
Food & Beverage$4,344 (78.4%)
Consulting$1,200 (21.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,344 | 165 | 78.4% |
| Consulting Fee | $1,200 | 1 | 21.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biohaven Pharmaceuticals, Inc. | $1,275 | 4 | $0 (2021) |
| Novo Nordisk Inc | $668.19 | 24 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $541.75 | 12 | $0 (2024) |
| Lilly USA, LLC | $367.09 | 23 | $0 (2024) |
| Amgen Inc. | $275.01 | 16 | $0 (2024) |
| ABBVIE INC. | $264.69 | 13 | $0 (2024) |
| Medtronic, Inc. | $244.93 | 2 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $168.15 | 8 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $153.58 | 7 | $0 (2023) |
| Boston Scientific Corporation | $145.46 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,242 | 49 | AstraZeneca Pharmaceuticals LP ($359.56) |
| 2023 | $1,029 | 36 | Janssen Scientific Affairs, LLC ($144.18) |
| 2022 | $923.39 | 32 | Novo Nordisk Inc ($280.26) |
| 2021 | $1,903 | 31 | Biohaven Pharmaceuticals, Inc. ($1,275) |
| 2020 | $19.69 | 1 | Takeda Pharmaceuticals U.S.A., Inc. ($19.69) |
| 2019 | $393.00 | 14 | Stryker Corporation ($103.03) |
| 2018 | $10.56 | 1 | Lilly USA, LLC ($10.56) |
| 2017 | $23.63 | 2 | Arbor Pharmaceuticals, Inc. ($12.14) |
All Payment Transactions
166 individual payment records from CMS Open Payments — Page 7 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2019 | Bioventus LLC | Durolane (Device) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Orthopedics/Orthopedic Surgery | ||||||
| 12/02/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/25/2019 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), VAQTA, GARDASIL9 | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: VACCINE | ||||||
| 10/04/2019 | Stryker Corporation | MAKO (Device), TRIATHLON | Food and Beverage | Cash or cash equivalent | $103.03 | General |
| Category: KNEES, HIPS | ||||||
| 08/29/2019 | ASSERTIO THERAPEUTICS, Inc. | Cambia (Drug), Gralise | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Neurology | ||||||
| 08/28/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2019 | Metuchen Pharmaceuticals | Stendra (Drug) | Food and Beverage | Cash or cash equivalent | $13.52 | General |
| Category: Erectile Dysfunction | ||||||
| 08/13/2019 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: Neuroscience | ||||||
| 08/09/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | Cash or cash equivalent | $81.79 | General |
| Category: KRYSTEXXA | ||||||
| 06/18/2019 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: NEUROSCIENCE | ||||||
| 05/14/2019 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: NEUROSCIENCE | ||||||
| 03/12/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Diabetes | ||||||
| 11/30/2018 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $10.56 | General |
| Category: Neuroscience | ||||||
| 05/25/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $11.49 | General |
| Category: Diabetes | ||||||
| 03/16/2017 | Arbor Pharmaceuticals, Inc. | Edarbi (Drug) | Food and Beverage | Cash or cash equivalent | $12.14 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 904 | 1,510 | $367,085 | $88,536 |
| 2022 | 15 | 681 | 1,312 | $275,581 | $64,001 |
| 2021 | 12 | 538 | 867 | $92,337 | $52,911 |
| 2020 | 15 | 591 | 1,065 | $86,038 | $56,756 |
Total Patients
2,714
Total Services
4,754
Medicare Billing
$262,205
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 220 | 526 | $195,672 | $41,277 | 21.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 147 | 147 | $55,272 | $17,026 | 30.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 91 | 125 | $32,875 | $7,136 | 21.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 32 | 42 | $21,924 | $5,252 | 24.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 16 | 17 | $13,617 | $3,257 | 23.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 38 | 38 | $2,850 | $2,793 | 98.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 138 | 138 | $7,314 | $2,407 | 32.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 13 | 13 | $7,683 | $2,057 | 26.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $9,760 | $1,968 | 20.2% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 15 | 23 | $8,932 | $1,949 | 21.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 39 | 39 | $1,950 | $1,179 | 60.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 22 | 107 | $4,387 | $871.26 | 19.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 14 | 15 | $2,265 | $604.80 | 26.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 24 | 29 | $870.00 | $266.56 | 30.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 16 | 18 | $162.00 | $151.20 | 93.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 27 | 177 | $708.00 | $147.58 | 20.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 14 | 14 | $602.00 | $124.08 | 20.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 18 | 22 | $242.00 | $71.61 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 201 | 516 | $166,770 | $36,803 | 22.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 99 | 99 | $33,726 | $8,651 | 25.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 71 | 93 | $22,197 | $4,916 | 22.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 44 | 44 | $20,040 | $3,918 | 19.5% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2022 | 22 | 30 | $9,952 | $2,663 | 26.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 93 | 93 | $4,515 | $1,658 | 36.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 14 | $6,405 | $1,373 | 21.4% |
About Dr. Scott Marberry, MD
Dr. Scott Marberry, MD is a Sports Medicine healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2014. The National Provider Identifier (NPI) number assigned to this provider is 1972914174.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Marberry, MD has received a total of $5,544 in payments from pharmaceutical and medical device companies, with $1,242 received in 2024. These payments were reported across 166 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($4,344).
As a Medicare-enrolled provider, Marberry has provided services to 2,714 Medicare beneficiaries, totaling 4,754 services with total Medicare billing of $262,205. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Sports Medicine
- Other Specialties Family Medicine
- Location Jacksonville, FL
- Active Since 05/11/2014
- Last Updated 08/25/2022
- Taxonomy Code 207QS0010X
- Entity Type Individual
- NPI Number 1972914174
Products in Payments
- NURTEC ODT (Drug) $1,389
- Saxenda (Drug) $331.67
- FARXIGA (Drug) $328.49
- Otezla (Drug) $275.01
- VRAYLAR (Drug) $249.50
- MOUNJARO (Drug) $218.22
- AIRSUPRA (Drug) $161.64
- STELARA (Biological) $144.18
- GIMOTI (Drug) $142.53
- SYNCHROMEDII (Device) $134.93
- WATCHMAN Access System (Device) $124.90
- Cologuard Collection Kit (Device) $115.42
- HawkOne (Device) $110.00
- ENTRESTO (Drug) $104.16
- Wegovy (Drug) $103.84
- MAKO (Device) $103.03
- TRINTELLIX (Drug) $91.89
- Rybelsus (Drug) $83.15
- KRYSTEXXA (Biological) $81.79
- TRULICITY (Drug) $74.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Sports Medicine Doctors in Jacksonville
Zachary Rogozinski, M.d, M.D
Sports Medicine — Payments: $60,367
Sports Medicine $60,367
Dr. Om Kapoor, Md, MD
Sports Medicine — Payments: $48,702
Sports Medicine $48,702
Johnny Washington, Md, MD
Sports Medicine — Payments: $14,495
Sports Medicine $14,495
Dr. Georges El Bahri, M.d, M.D
Sports Medicine — Payments: $9,279
Sports Medicine $9,279
Kevin Murphy, Md, MD
Sports Medicine — Payments: $6,969
Sports Medicine $6,969
Dr. Wesley Mills, M.d, M.D
Sports Medicine — Payments: $4,387
Sports Medicine $4,387